Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236313 · ClinicalTrials.gov registry record
Aortic Wall and Left Ventricular Mechanics: Echocardiographic and Hemodynamic Analysis
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 51
- Enrollment target
NCT01236313: Clinical Trial study, sponsored by Weill Medical College of Cornell University.
NCT01236313 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01236313 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively determine the relationship between the dimensions of the aorta (the large artery taking off the heart) and blood pressure during cardiac surgery.
Interventions
- PROCEDURE TEE report
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-03 |
Why NCT01236313 stopped before completion
NCT01236313 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which TEE report is the first listed.
NCT01236313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01236313 about?
NCT01236313 is a clinical study titled "Aortic Wall and Left Ventricular Mechanics: Echocardiographic and Hemodynamic Analysis". The purpose of this study is to prospectively determine the relationship between the dimensions of the aorta (the large artery taking off the heart) and blood pressure during cardiac surgery.
What is the current status of trial NCT01236313?
This trial is currently terminated. The enrollment target is 51 participants. The study started on 2010-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01236313?
The interventions under investigation include: TEE report (PROCEDURE).
Who is sponsoring clinical trial NCT01236313?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia